Nano-X Imaging (NNOX)
Develops Nanox.ARC imaging systems, AI tools, radiology services, and health IT.
Something off on this page? Send us feedback.
Sells an imaging platform built around Nanox.ARC hardware, Nanox.CLOUD, AI software, radiology services, marketplace tools, and health IT. Hardware commercialization remains early, while revenue also comes from acquired service and software businesses.
Builds a medical-imaging platform around a digital X-ray source intended to lower the cost and footprint of routine imaging systems. The core stack combines Nanox.ARC hardware, Nanox.CLOUD connectivity, Nanox.AI analytics, USARAD-based radiology services, Nanox.MARKETPLACE, and Nanox Health IT.
Operates from Israel with a Nasdaq-listed issuer formed from predecessor imaging assets. FDA clearances have expanded Nanox.ARC from adult musculoskeletal tomosynthesis to broader adult adjunctive radiography indications, with Nanox.ARC X cleared as an AI-ready system.
Execution depends on converting cleared systems into deployed hardware revenue while acquired services and software carry the broader platform. Commercialization remains early, annual revenue guidance was withdrawn, and past securities litigation and SEC matters were resolved through settlements and agreements.
Company facts
Categories
Target rangeAs of Sep 2, 2026
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Target |
|---|---|---|---|---|---|
| Jul 7, 2026 | Industrial Alliance Securities | Target | $3 | ||
| Jul 7, 2026 | Alliance Global Partners | Downgrade | Buy | Neutral |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Mar 31, 2026Cash & short-term investments $43.9M · Total debt $7.6M · Total assets $145.8M · Shareholders' equity $126.3M
- Revenue
- $4.3M
- Operating income
- −$14.8M
- Net income
- −$14.3M
No dividends on record.
| Institutions107 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | ≈ 13.84% | 9.63M ADS | |
| Insiders17 holders · as of Aug 11, 2026 | 25.89% | 18.02M ADS | |
| Strategic holders1 holder · as of Mar 5, 2021 | 3.61% | 2.51M ADS | |
| Otherremainder | ≈ 56.66% | 39.44M ADS |
69.60M ADS as of Aug 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Dec 2022 annual report; nothing newer is on file here.
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Moalem MosheInsider | 7.56% | 5.26M | 13Gfiled Jul 15, 2026 ↗ |
of 5 pagesInsider | 7.00% | 4.87M | 13Gfiled Feb 14, 2022 ↗ |
Ran PoliakineInsider | 6.91% | 4.81M | 13Gfiled Feb 16, 2021 ↗ |
B. StoneInsider | 3.77% | 2.62M | 13Gfiled Feb 12, 2021 ↗ |
YOZMA GROUP KOREA Co., Ltd.Strategic | 3.61% | 2.51M | 13Gfiled Mar 5, 2021 ↗ |
| See all 25 → | |||
13D/13G — an ownership statement filed at 5% or more
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 10, 2026 | Erez Meltzer | director, officer: Chief Executive Officer | +9,443 | $1.03 |
| Jul 28, 2026 | Noga Kainan | director | +33,000 | $0.9000 |
| Jul 27, 2026 | Dan S. Suesskind | director | +50,000 | $0.9300 |
| Jul 27, 2026 | Erez Meltzer | director, officer: Chief Executive Officer | +36,000 | $0.9300 |
| Jun 10, 2026 | Erez Alroy | director | −678 | $1.65 |
- GE HealthCare
Broad X-ray, imaging software, and AI workflow overlap
- Philips (ADR)
Diagnostic imaging, PACS, and AI-enabled radiology overlap
- RadNet
Public radiology-services, PACS, and clinical AI overlap
ComparePre-market
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Nano-X Imaging | $0.8000 | +4.77% | $53.2M | — | — | 3.7 | +24.0% |
| GE HealthCare | $70.66 | +0.17% | $31.87B | 20.5 | 13.6 | 1.6 | +5.8% |
| Philips (ADR) | $26.22 | −0.62% | $25.77B | 19.6 | 13.5 | 1.3 | −2.9% |
| RadNet | $75.90 | +0.29% | $5.95B | — | 111.9 | 2.6 | +25.0% |
| Median | 20.0 | 13.6 | 1.6 | +5.8% |